Literature DB >> 11146708

Is it worth treating fever in intensive care unit patients? Preliminary results from a randomized trial of the effect of external cooling.

V Gozzoli1, P Schöttker, P M Suter, B Ricou.   

Abstract

BACKGROUND: Antipyresis is a common clinical practice in intensive care, although it is unknown if fever is harmful, beneficial, or a negligible adverse effect of infection and inflammation.
METHODS: In a randomized study, rectal temperature and discomfort were assessed in 38 surgical intensive care unit patients without neurotrauma or severe hypoxemia and with fever (temperature >/=38.5 degrees C) and systemic inflammatory response syndrome. Eighteen patients received external cooling while 20 received no antipyretic treatment.
RESULTS: Temperature and discomfort decreased similarly in both groups after 24 hours. No significant differences in recurrence of fever, incidence of infection, antibiotic therapy, intensive care unit and hospital length of stay, or mortality were noted between the groups.
CONCLUSIONS: These results suggest that the systematic suppression of fever may not be useful in patients without severe cranial trauma or significant hypoxemia. Letting fever take its natural course does not seem to harm patients with systemic inflammatory response syndrome or influence the discomfort level and may save costs.

Entities:  

Mesh:

Year:  2001        PMID: 11146708     DOI: 10.1001/archinte.161.1.121

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  21 in total

1.  Clinical and demographic factors associated with antipyretic use in gram-negative severe sepsis and septic shock.

Authors:  Nicholas M Mohr; Brian M Fuller; Lee P Skrupky; Hawnwan Moy; Robert Alunday; Scott T Micek; Richard E Fagley
Journal:  Ann Pharmacother       Date:  2011-09-20       Impact factor: 3.154

2.  Fever: suppress or let it ride?

Authors:  Juliet J Ray; Carl I Schulman
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

3.  Acetaminophen in critically ill patients, a therapy in search for big data analytics.

Authors:  Sven Van Poucke; Willem Boer
Journal:  J Thorac Dis       Date:  2016-01       Impact factor: 2.895

Review 4.  [Antipyretics in intensive care patients].

Authors:  A Simon; A Leffler
Journal:  Anaesthesist       Date:  2017-07       Impact factor: 1.041

5.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  Acute Med Surg       Date:  2018-02-05

6.  Early antipyretic exposure does not increase mortality in patients with gram-negative severe sepsis: a retrospective cohort study.

Authors:  Nicholas Mohr; Lee Skrupky; Brian Fuller; Hawnwan Moy; Robert Alunday; Michael Wallendorf; Scott Micek; Richard Fagley
Journal:  Intern Emerg Med       Date:  2012-08-28       Impact factor: 3.397

7.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  J Intensive Care       Date:  2018-02-02

Review 8.  Clinical review: fever in septic ICU patients--friend or foe?

Authors:  Yoann Launey; Nicolas Nesseler; Yannick Mallédant; Philippe Seguin
Journal:  Crit Care       Date:  2011-06-07       Impact factor: 9.097

9.  Assessment of the safety and feasibility of administering anti-pyretic therapy in critically ill adults: study protocol of a randomized trial.

Authors:  Daniel J Niven; Caroline Léger; Paul Kubes; H Tom Stelfox; Kevin B Laupland
Journal:  BMC Res Notes       Date:  2012-03-16

10.  Randomized trial of the effect of intravenous paracetamol on inflammatory biomarkers and outcome in febrile critically ill adults.

Authors:  Hooshyar Honarmand; Mohammad Abdollahi; Arezoo Ahmadi; Mohammad Reza Javadi; Mohammad Reza Khoshayand; Hamed Tabeefar; Sarah Mousavi; Laleh Mahmoudi; Mania Radfar; Atabak Najafi; Mojtaba Mojtahedzadeh
Journal:  Daru       Date:  2012-08-28       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.